0000899243-20-031964.txt : 20201123
0000899243-20-031964.hdr.sgml : 20201123
20201123190344
ACCESSION NUMBER: 0000899243-20-031964
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201119
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Anthony
CENTRAL INDEX KEY: 0001606030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 201339475
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-19
0
0000730272
REPLIGEN CORP
RGEN
0001606030
Hunt Anthony
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
Chief Executive Officer
Common Stock
2020-11-19
4
M
0
20000
26.05
A
253327
D
Common Stock
2020-11-19
4
S
0
5447
184.69
D
247880
D
Common Stock
2020-11-19
4
S
0
6823
185.67
D
241057
D
Common Stock
2020-11-19
4
S
0
6300
186.50
D
234757
D
Common Stock
2020-11-19
4
S
0
1430
187.60
D
233327
D
Stock Option (Right to Buy)
26.05
2020-11-19
4
M
0
20000
0.00
D
2026-02-26
Common Stock
20000
0
D
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 11, 2020.
$184.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.11 to $185.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$185.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.12 to $186.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$186.50 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.12 to $187.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$187.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.19 to $189.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is currently exercisable.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2020-11-23